Angioscopic study of the antithrombotic effect of a new selective thromboxane A2 synthetase inhibitor, CV-4151, on experimental arterial thrombi
- 31 October 1989
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 118 (4) , 837-839
- https://doi.org/10.1016/0002-8703(89)90597-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism.Circulation Research, 1988
- Arachidonate metabolism in myocardial ischemia and reperfusionJournal of Molecular and Cellular Cardiology, 1988
- Thromboxane release during percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1986
- Cv-4151 — a potent, selective thromboxane A2synthetase inhibitorThrombosis Research, 1986
- Thromboxane A2 in acute myocardial infarctionAmerican Heart Journal, 1984
- Acute coronary events associated with percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1984
- Lack of effect of aspirin on myocardial infarct size in the dogThe American Journal of Cardiology, 1981
- Influence of thromboxane inhibition on the severity of myocardial ischemia in catsCanadian Journal of Physiology and Pharmacology, 1980
- Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.Journal of Clinical Investigation, 1976